Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No PR to Explain USPTO Developments

How do you know that recertification of '336 isn't currently on hold?

TPL feels pretty confident of a recert. And if you go by the schedule of the 584, which took 10 weeks from RXNIRC to publication. That places the 336 publication (RXNIRC filed 9/11/09) at either this week or next.


Share
New Message
Please login to post a reply